News

Boston Scientific Corp. and Asahi Intecc have formalized plans to develop a new, differentiated fractional flow reserve (FFR) wire. 

August 15, 2014 — Zoll Medical Corp. announced its Japanese subsidiary, Asahi Kasei Zoll Medical (AZM), has received Shonin approval from the Japanese Ministry of Health, Labour and Welfare to...

SunTech Centron Diagnostics Central Blood Pressure Technology

SunTech Medical acquired King’s College London’s central blood pressure technology as well as the assets of Centron Diagnostics Ltd., including the clinically-validated cBP301 Central Blood...

August 12, 2014 — Like clues to a crime, specific molecules in the body can hint at exposure to toxins, infectious agents or even trauma, and therefore help doctors determine whether and how to...

August 6, 2014 — St. Jude Medical announced the Center for Medicare and Medicaid Services (CMS) has approved a new technology add-on payment (NTAP) for the CardioMEMS heart failure (HF)...

Medtronic, Acist Agreement FFR-IVUS Technologies

Acist Medical Systems entered into a strategic agreement with Medtronic to co-promote the world’s first Rapid Exchange FFR (RXi) and high definition IVUS (HDi) technologies in the United States....

OSTAR Healthcare Technology P200 Remote Blood Pressure Monitoring System

OSTAR Healthcare Technology, a Washington State-based Medical Device and Healthcare IT company, announced the North American launch of its P Series Cloud Based Telehealth Blood Pressure Monitoring...

August 4, 2014 — Ostar Healthcare Technology, a Washington-based medical device and healthcare IT company, announced the North American launch of its P Series cloud-based telehealth blood pressure...

STEMI, inaccurate ECG reads

In a community hospital and emergency medical services (EMS) system, the standard 12-lead electrocardiogram (ECG) is the primary and initial objective diagnostic tool used by emergency medical...

Robert Smith, a cardiologist at Saint Francis Hospital and Medical Center in Hartford, Conn., released the results of his retrospective study designed to compare single in-office automated blood...

July 24, 2014 — Boston Scientific has initiated full commercial launch of its new Polaris imaging system. This system will support the Boston Scientific family of intravascular ultrasound (IVUS)...

reveal linq, icm

Texas Cardiac Arrhythmia Institute at St. David's Medical Center was among the first in the United States to implant the Medtronic Reveal LINQ Insertable Cardiac Monitor System in a patient....

EndoPAT diagnostic device

Data from a new study indicate that the results of an FDA-approved test for endothelial (arterial) function significantly correlated with near-future cardiovascular events, of which the majority...

heart attacks, women's health

A new look at hospital data shows women have longer hospital stays and are more likely than men to die in the hospital after a heart attack.

July 18, 2014 — AliveCor announced that more than one million ECGs (electrocardiograms) have been recorded using the AliveCor heart monitor since the first ECG was recorded in January...

July 15, 2014 — Telemed Solutions has reached an agreement with GlobalMedia Group LLC to become the exclusive global distributor for the TM-12, a PC-based wireless resting 12-lead ECG (...

In the current era of healthcare reform with the overarching goal of reducing healthcare costs, heart failure (HF) management has taken center stage. It is the leading cause of hospitalization for...

Vital Connect announced its HealthPatch MD biosensor has received U.S. Food and Drug Administration (FDA) clearance. The solution is capable of capturing clinical-grade biometric measurements and...

Medtronic Reveal XT ICM CRYSTAL AF Clinical Trial Atrial Fibrillation

Medtronic Inc. announced results from the CRYSTAL AF (CRYptogenic STroke And underLying Atrial Fibrillation) clinical trial, published in The New England Journal of Medicine. The trial found that...

LipoScience Inc. announced the publication of the first large-scale real world study evidencing a link between low LDL-P and reduced cardiovascular disease (CVD) risk.